AI Analysis
AI-generated analysis. Always verify with the original filing.
Nasus Pharma Ltd. filed Exhibit 99.1 containing its Amended and Restated Articles of Association under the Israeli Companies Law, 1999. The amendments define key terms, confirm the company's status as a public limited liability company, authorize 50,000,000 no par-value Ordinary Shares, and outline governance provisions for share capital changes, issuance, and shareholder rights.
Key Takeaways
1Company is Nasus Pharma Ltd., a public company under Israeli Companies Law.
2Authorized share capital: 50,000,000 Ordinary Shares, no par-value, ranking pari passu.
3Board of Directors controls issuance of unissued shares and convertible securities.
4Shareholders may increase authorized capital by resolution.
5Company may repurchase shares subject to Companies Law.
6Articles permit donations for purposes deemed appropriate by Board.